Papers

4

Total Citations

213

H-Index

3

About

Johannes Kuosmanen is a pioneering researcher at the intersection of robotics, drug delivery, and gastrointestinal medicine. His work focuses on developing ingestible robotic devices that overcome the body’s natural barriers to transform how therapies are administered and how the gut is diagnosed and treated. Kuosmanen’s most influential contribution is the **RoboCap**—a robotic mucus-clearing capsule that physically disrupts the luminal mucus barrier to enable oral delivery of protein drugs, a feat previously requiring injections. This work has garnered over 114 citations and represents a paradigm shift in non-invasive macromolecule administration. He further advanced the field with **cephalopod-inspired jetting devices** that inject biomacromolecules directly into gastrointestinal tissue, eliminating the need for traditional needles and sharps waste. Kuosmanen also developed an **ingestible, battery-free, tissue-adhering robotic interface** for chronic electrostimulation of the gut, addressing critical limitations of poor electrode contact and short dwell time. His combined work—cited over 200 times—demonstrates a unique ability to merge bioinspiration, soft robotics, and clinical need, positioning him as a leading innovator in next-generation gastrointestinal therapeutics and diagnostics.

Research Focus

Key Achievements

3
H-Index
4
Papers
213
Total Citations
53
Avg Citations/Paper
🏆 Most Cited Paper
RoboCap: Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract
114 citations · 2022
📈 Most Prolific Year: 2024 (3 Papers)
🤝 Key Collaborators: 69
🏛 Institutions: Massachusetts Institute of Technology, Brigham and Women's Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago